Replies to post #2430 on Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Absolutely agree on both counts. If my guesstimate is anywhere near right

if it took 14.5m to enroll 87 pts, and say due to the ramp up of trial sites, it took two-thirds of 14.5m to enroll half the patients (i.e. ~44 patients). Two-thirds of the time from Sept 13, 2017 (start of trial) to Dec 31, 2018 (full enrollment) is roughly 9.5 months or end of June 2018. - post 2416

so 44 patients already have been on trial for 7 months. The FDA asked for data on 30 patients from the MDA trial for BTD. If 30 patients have been recruited by March 2018 (30 pts / 44 pts = .68 * 9.5m = 6.5 months), those 30 patients would be 1 year on the trial by end of March 2019 and provide mature enough data for BTD. Say one month to finalize data and submit the BTD application and 2 months for the agency to get back to them takes it to the end of June. Fourth of July fireworks is always special perhaps that includes Spectrum’s share price too. IMHO

Ditto on improved results.